SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001857
Filing Date
2019-03-12
Accepted
2019-03-12 16:58:39
Documents
80
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20181231x10k.htm 10-K 3175985
2 EX-10.27 knsa-20181231ex102759b01.htm EX-10.27 153737
3 EX-23.1 knsa-20181231ex23130816f.htm EX-23.1 2773
4 EX-31.1 knsa-20181231ex311e6e0da.htm EX-31.1 15618
5 EX-31.2 knsa-20181231ex3120bfd50.htm EX-31.2 15580
6 EX-32.1 knsa-20181231ex321be0fcc.htm EX-32.1 8273
7 EX-32.2 knsa-20181231ex3220b66cc.htm EX-32.2 8154
8 GRAPHIC knsa20181231x10k001.jpg GRAPHIC 117957
9 GRAPHIC knsa20181231x10k002.jpg GRAPHIC 198006
  Complete submission text file 0001558370-19-001857.txt   9835714

Data Files

Seq Description Document Type Size
10 EX-101.INS knsa-20181231.xml EX-101.INS 1587049
11 EX-101.SCH knsa-20181231.xsd EX-101.SCH 65758
12 EX-101.CAL knsa-20181231_cal.xml EX-101.CAL 52399
13 EX-101.DEF knsa-20181231_def.xml EX-101.DEF 307486
14 EX-101.LAB knsa-20181231_lab.xml EX-101.LAB 571175
15 EX-101.PRE knsa-20181231_pre.xml EX-101.PRE 465059
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 19675736
SIC: 2834 Pharmaceutical Preparations